Bouvel Investment Partners, LLC Adaptive Biotechnologies Corp Transaction History
Bouvel Investment Partners, LLC
- $239 Million
- Q2 2024
A detailed history of Bouvel Investment Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 45,880 shares of ADPT stock, worth $232,152. This represents 0.07% of its overall portfolio holdings.
Number of Shares
45,880
Previous 46,030
0.33%
Holding current value
$232,152
Previous $147,000
12.93%
% of portfolio
0.07%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
187Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$152 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$70.8 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$59 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$58.6 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$57.7 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $723M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...